WITHDRAWN: Effective suppression of Rituximab-resistant B-cell lymphoma by a comb-like anti-CD20 mAb nanocluster

Huafei Li; Zheng Xu; Cong Wu; He Zhao; Ge Zhang; Huajing Wang; Changhong Ke; Bohua Li; Yajun Guo

doi:10.1016/j.canlet.2015.02.025

WITHDRAWN: Effective suppression of Rituximab-resistant B-cell lymphoma by a comb-like anti-CD20 mAb nanocluster

Cancer Lett. 2015 Feb 23:S0304-3835(15)00129-9. doi: 10.1016/j.canlet.2015.02.025. Online ahead of print.

Authors

Huafei Li¹, Zheng Xu², Cong Wu³, He Zhao⁴, Ge Zhang⁴, Huajing Wang⁴, Changhong Ke⁴, Bohua Li⁴, Yajun Guo⁵

Affiliations

¹ International Joint Cancer Institute, The Second Military Medical University, Shanghai, China; Planning Division, Ministry of Scientific Research, The Second Military Medical University, Shanghai, China. Electronic address: [email protected].
² Planning Division, Ministry of Scientific Research, The Second Military Medical University, Shanghai, China.
³ Department of laboratory diagnosis, Changhai Hospital Affiliated to the Second Military Medical University, Shanghai, China.
⁴ International Joint Cancer Institute, The Second Military Medical University, Shanghai, China.
⁵ International Joint Cancer Institute, The Second Military Medical University, Shanghai, China. Electronic address: [email protected].

PMID: 25721087
DOI: 10.1016/j.canlet.2015.02.025

Abstract

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.